HK1159612A1 - Aminopropylidene derivative - Google Patents

Aminopropylidene derivative

Info

Publication number
HK1159612A1
HK1159612A1 HK11113986.6A HK11113986A HK1159612A1 HK 1159612 A1 HK1159612 A1 HK 1159612A1 HK 11113986 A HK11113986 A HK 11113986A HK 1159612 A1 HK1159612 A1 HK 1159612A1
Authority
HK
Hong Kong
Prior art keywords
aminopropylidene derivative
aminopropylidene
derivative
Prior art date
Application number
HK11113986.6A
Other languages
English (en)
Chinese (zh)
Inventor
Kunihiko Higashiura
Takashi Ogino
Taizo Ito
Koji Kunimasu
Kazuhito Furukawa
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Publication of HK1159612A1 publication Critical patent/HK1159612A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK11113986.6A 2008-08-01 2011-12-28 Aminopropylidene derivative HK1159612A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008199648 2008-08-01
JP2009127385 2009-05-27
PCT/JP2009/063645 WO2010013805A1 (ja) 2008-08-01 2009-07-31 アミノプロピリデン誘導体

Publications (1)

Publication Number Publication Date
HK1159612A1 true HK1159612A1 (en) 2012-09-21

Family

ID=41610499

Family Applications (2)

Application Number Title Priority Date Filing Date
HK11113986.6A HK1159612A1 (en) 2008-08-01 2011-12-28 Aminopropylidene derivative
HK15107411.9A HK1206742A1 (en) 2008-08-01 2015-08-03 Aminopropylidene derivative

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK15107411.9A HK1206742A1 (en) 2008-08-01 2015-08-03 Aminopropylidene derivative

Country Status (16)

Country Link
US (1) US8653285B2 (de)
EP (1) EP2319840B1 (de)
JP (2) JP5379139B2 (de)
KR (1) KR101375680B1 (de)
CN (2) CN102112462B (de)
AU (1) AU2009277496B2 (de)
BR (1) BRPI0917550A2 (de)
CA (1) CA2732282C (de)
DK (1) DK2319840T3 (de)
ES (1) ES2561227T3 (de)
HK (2) HK1159612A1 (de)
PL (1) PL2319840T3 (de)
PT (1) PT2319840E (de)
RU (1) RU2483063C2 (de)
TW (1) TWI457341B (de)
WO (1) WO2010013805A1 (de)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1502857A (fr) * 1965-10-01 1967-11-24 Sandoz Sa Nouveaux dérivés du benzo-cyclohepta-thiophène et leur préparation
CH531000A (de) * 1970-03-11 1972-11-30 Sandoz Ag Verfahren zur Herstellung neuer Benzocycloheptathiophene
JPS522393Y2 (de) * 1971-02-15 1977-01-19
CH568312A5 (de) * 1972-01-24 1975-10-31 Sandoz Ag
SE388858B (sv) 1972-09-20 1976-10-18 Sandoz Ag Analogiforfarande for framstellning av nya 2-alkyl-4(1-alkyl-4-piperidyliden)bensocykloheptatiofenderivat
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
US4882351A (en) * 1987-10-14 1989-11-21 Roussel Uclaf Tricyclic compounds
JPH06310784A (ja) 1993-04-22 1994-11-04 Olympus Optical Co Ltd 半導体レーザの駆動装置
JP3338913B2 (ja) * 1993-06-29 2002-10-28 大鵬薬品工業株式会社 テトラゾール誘導体
US6613905B1 (en) * 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
EA015491B1 (ru) 2003-06-27 2011-08-30 Янссен Фармацевтика Н.В. ТРИЦИКЛИЧЕСКИЕ δ-ОПИОИДНЫЕ МОДУЛЯТОРЫ
MX2007016247A (es) * 2005-06-17 2008-03-10 Janssen Pharmaceutica Nv Derivados de tetrahidrofurano tetraciclicos novedosos que contienen una cadena lateral de amida ciclica.
JP2008019121A (ja) 2006-07-12 2008-01-31 Babcock Hitachi Kk 水素製造装置
AU2007301145B2 (en) 2006-09-29 2012-12-13 Nippon Zoki Pharmaceutical Co., Ltd. Oxepin derivative
WO2009096080A1 (ja) * 2008-01-30 2009-08-06 Nippon Zoki Pharmaceutical Co., Ltd. ピペリジン誘導体

Also Published As

Publication number Publication date
BRPI0917550A2 (pt) 2015-11-17
EP2319840A4 (de) 2012-05-16
CN104693215A (zh) 2015-06-10
KR20110049773A (ko) 2011-05-12
DK2319840T3 (en) 2016-01-25
RU2011107744A (ru) 2012-09-10
PL2319840T3 (pl) 2016-03-31
CN102112462B (zh) 2015-02-18
JP5503793B2 (ja) 2014-05-28
TW201011038A (en) 2010-03-16
US8653285B2 (en) 2014-02-18
JPWO2010013805A1 (ja) 2012-01-12
WO2010013805A1 (ja) 2010-02-04
TWI457341B (zh) 2014-10-21
AU2009277496B2 (en) 2013-09-26
CA2732282C (en) 2016-03-29
JP2013253115A (ja) 2013-12-19
CN104693215B (zh) 2017-09-01
US20110124856A1 (en) 2011-05-26
RU2483063C2 (ru) 2013-05-27
EP2319840A1 (de) 2011-05-11
CN102112462A (zh) 2011-06-29
CA2732282A1 (en) 2010-02-04
AU2009277496A1 (en) 2010-02-04
JP5379139B2 (ja) 2013-12-25
HK1206742A1 (en) 2016-01-15
KR101375680B1 (ko) 2014-03-19
ES2561227T3 (es) 2016-02-25
EP2319840B1 (de) 2015-12-16
PT2319840E (pt) 2016-02-10

Similar Documents

Publication Publication Date Title
HK1256310A1 (zh) N-磺酰基吡咯衍生物
EP2376493A4 (de) Dihydropyrimidopyrimidinderivat
EP2380877A4 (de) Pyridin-3-carbonsäureamidderivat
IL210548A0 (en) Spiroaminodihydrothiazine derivatives
EP2376494A4 (de) Dihydropyrimidopyrimidinderivate
PL2308877T3 (pl) Pochodne imidazopirydyn-2-onu
HK1158189A1 (en) Morpholinopurine derivative
EP2269993A4 (de) 2-aminochinazolin-derivat
SG10201506608RA (en) 3-deazaneplanocin derivatives
IL210406A0 (en) Pyrrolopyridinylpyrimidin - 2 - ylamine derivatives
EP2291078A4 (de) Oxazolbenzimidazolderivate
ZA201005769B (en) Bicycloamine derivative
EP2279532A4 (de) Oxazolbenzimidazolderivate
IL208623A0 (en) Cyclopentylacrylamide derivative
IL210869A0 (en) Imidazothiadiazoles derivatives
IL208336A0 (en) Pyrisazinone derivatives
IL210164A0 (en) Thiazolylpiperidine derivatives
ZA201008052B (en) 2-phenyl-4-cyclopropyl-pyrimidine derivatives
IL213424A0 (en) Quinazolinamide derivatives
ZA201006992B (en) Hydroxyquinoxalinecarboxamide derivative
EP2292613A4 (de) Dihydroindolinonderivate
EP2248811A4 (de) 2-oxochromen-derivat
IL212683A0 (en) Biphenylacetamide derivative
EP2332925A4 (de) Neuartiges dihydrotriazinderivat
EP2328892A4 (de) Oxotetrahydrofuran-2-yl-benzimidazolderivat

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190727